Large-scale human study finds Ozempic (or similar medications) may reduce opioid overdose risk by 40%
A study published in the journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar medications to treat diabetic/weight-related conditions appear to have a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than people with OUD and AUD who do not take Ozempic or similar medications.
Ozempic (and similar medications) may be the new treatment for opioid and alcohol use disorder
A new study published in the scientific journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar medications to treat diabetic/weight-related conditions appear to have a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than people with OUD and AUD who do not take Ozempic or similar medications.
Ozempic and similar drugs may lower risks for opioid and alcohol use disorders
A new study published in the scientific journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar medications to treat diabetic/weight-related conditions appear to have a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than people with OUD and AUD who do not take Ozempic or similar medications.
Ozempic: Weight Loss Drug May Help With Addiction Too
These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.
Weight loss drugs like Ozempic may help reduce overdose risks: Study
A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.
Weight-loss drugs show promise in tackling opioid and alcohol abuse
Ozempic and similar products cut opioid and alcohol abuse by up to half, according to research that adds to evidence of the hugely popular blockbuster drugs’ broad potential beyond tackling obesity and diabetes.
Could Ozempic and similar drugs be used to treat substance use disorders?
One of the most prominent medical developments in recent years has been the emergence of a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The best known of these drugs is Ozempic,
The Case for Ozempic as a Addiction Treatment Keeps Getting Better
Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's addiction to both opioids and alcohol.
Ozempic Could Be Used to Treat Alcohol and Drug Addiction, Study Finds
In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.
rheumatologyadvisor43m
Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a previous metformin ...
Medical Xpress15h
Bariatric surgery found to be more cost effective than newer weight loss drugs alone
Further, a second study presented at the meeting found that this increasingly popular class of weight-loss drugs, called ...
Ozempic could cut binge drinking and opioid abuse
Ozempic could cut binge drinking and opioid abuse, major research suggests. A US study of more than 800,000 people with a ...
healthday on MSN2d
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...
ahajournals.org7d
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...
News Medical on MSN3d
Dietitians boost GLP-1 therapy success with personalized care and side effect management
Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...
Night Helper Blog LLC on MSN1mon
Ozempic for Weight Loss: A Comprehensive Guide
Ozempic is a prescription drug that features semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Initially ...
Response begins enrolment for trial of RDX-002 for weight management
Response Pharmaceuticals has initiated subject enrolment for a Phase II trial of its drug candidate RDX-002, designed to ...